Compare NRDS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRDS | ABCL |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 910.0M |
| IPO Year | 2021 | 2020 |
| Metric | NRDS | ABCL |
|---|---|---|
| Price | $9.91 | $3.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $14.33 | $7.75 |
| AVG Volume (30 Days) | 1.1M | ★ 3.0M |
| Earning Date | 05-27-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 68.42 | 10.91 |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $836,600,000.00 | $75,128,000.00 |
| Revenue This Year | $8.80 | N/A |
| Revenue Next Year | $8.14 | $16.59 |
| P/E Ratio | $16.20 | ★ N/A |
| Revenue Growth | 21.67 | ★ 160.56 |
| 52 Week Low | $7.55 | $1.89 |
| 52 Week High | $16.24 | $6.52 |
| Indicator | NRDS | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 48.71 |
| Support Level | $8.95 | $3.37 |
| Resistance Level | $11.39 | $3.57 |
| Average True Range (ATR) | 0.61 | 0.22 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 25.22 | 50.97 |
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.